Effect of zonisamide on essential tremor: a pilot crossover study in comparison with arotinolol
- 1 March 2005
- journal article
- clinical trial
- Published by Elsevier in Parkinsonism & Related Disorders
- Vol. 11 (2) , 101-103
- https://doi.org/10.1016/j.parkreldis.2004.09.004
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Novel Therapeutic Effects of the Anti-Convulsant, Zonisamide, on Parkinsons DiseaseCurrent Pharmaceutical Design, 2004
- A multicenter randomized crossover multiple-dose comparison study of arotinolol and propranolol in essential tremorParkinsonism & Related Disorders, 2003
- Mirtazapine in essential tremor: A double‐blind, placebo‐controlled pilot studyMovement Disorders, 2003
- Zonisamide has beneficial effects on Parkinson's disease patientsNeuroscience Research, 2001
- Bilateral thalamic stimulation for the treatment of essential tremorNeurology, 1999
- Interaction between Ca2+, K+, carbamazepine and zonisamide on hippocampal extracellular glutamate monitored with a microdialysis electrodeBritish Journal of Pharmacology, 1998
- The anticonvulsant zonisamide scavenges free radicalsEpilepsy Research, 1998
- Effects of zonisamide on extracellular levels of monoamine and its metabolite, and on Ca2+ ependent dopamine releaseEpilepsy Research, 1992
- Zonisamide blocks T-type calcium channel in cultured neurons of rat cerebral cortexEpilepsy Research, 1992